Abstract
Vascular calcifications are common among patients with hypertension. The vitamin K–dependent protein matrix Gla-protein plays an important role in preventing arterial calcification. Since a decrease in renal clearance is a prevalent clinical problem in patients with hypertension, we aimed to study the renal clearance of matrix Gla-protein from the circulation in these patients having a wide range of creatinine clearances. Ninety moderate to severe hypertensive patients who were scheduled for renal angiography were enrolled in the study. In these patients, renal arterial and renal venous blood was sampled prior to the administration of contrast material in order to determine the total renal and single kidney clearance of matrix Gla-protein. The average renal fractional extraction of matrix Gla-protein was 12.8%. There was no significant correlation between creatinine clearance (range 26–154) and renal fractional extraction of matrix Gla-protein in this population. The extraction of matrix Gla-protein was not influenced by the presence of a renal artery stenosis. In conclusion, we demonstrate that the kidney is able to extract matrix Gla-protein from the plasma at a constant level of 12.8%, independent of renal function in hypertensive subjects.
Similar content being viewed by others
Article PDF
References
Fogteloo AJ, Meinders AE, Pijl H, Kroon AA, Frolich M, De Leeuw PW : Renal clearance of endogenous leptin in hypertensive humans with or without renal artery stenosis. Am J Physiol Endocrinol Metab 2001; 281: E400–E404.
Buijs MM, de Leeuw PW, Houben AJ, et al: Renal contribution to increased clearance of exogenous growth hormone in obese hypertensive patients. J Clin Endocrinol Metab 2005; 90: 795–799.
Price PA, Urist MR, Otawara Y : Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 1983; 117: 765–771.
Luo G, Ducy P, McKee MD, et al: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78–81.
Dhore CR, Cleutjens JP, Lutgens E, et al: Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001; 21: 1998–2003.
Price PA, Faus SA, Williamson MK : Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998; 18: 1400–1407.
Farzaneh-Far A, Davies JD, Braam LA, et al: A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels. J Biol Chem 2001; 276: 32466–32473.
Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL : High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 1994; 93: 2393–2402.
Price PA, Thomas GR, Pardini AW, Figueira WF, Caputo JM, Williamson MK : Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronatetreated rats. J Biol Chem 2002; 277: 3926–3934.
Braam LA, Dissel P, Gijsbers BL, et al: Assay for human matrix Gla protein in serum: potential applications in the cardiovascular field. Arterioscler Thromb Vasc Biol 2000; 20: 1257–1261.
Jono S, Ikari Y, Vermeer C, et al: Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography. Thromb Haemost 2004; 91: 790–794.
Schurgers LJ, Teunissen KJ, Knapen MH, et al: Characteristics and performance of an immunosorbent assay for human matrix Gla-protein. Clin Chim Acta 2005; 351: 131–138.
Hermans MM, Vermeer C, Kooman JP, et al: Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation index. Blood Purif 2007; 25: 395–401.
Cetin M, Cetin R, Tamer N : Prevalence of breast arterial calcification in hypertensive patients. Clin Radiol 2004; 59: 92–95.
Anderson GH Jr, Blakeman N, Streeten DH : Prediction of renovascular hypertension. Comparison of clinical diagnostic indices. Am J Hypertens 1988; 1: 301–304.
Krijnen P, van Jaarsveld BC, Steyerberg EW, Man in 't Veld AJ, Schalekamp MA, Habbema JD : A clinical prediction rule for renal artery stenosis. Ann Intern Med 1998; 129: 705–711.
Detection, evaluation, and treatment of renovascular hypertension. Final report. Working Group on Renovascular Hypertension. Arch Intern Med 1987; 147: 820–829.
de Leeuw PW, Birkenhager WH : Use of the xenon-133 washout technique in diagnosing renovascular disease in hypertension. Nephron 1986; 44 ( Suppl 1): 5–7.
Ladefoged J : Measurements of the renal blood flow in man with the 133 xenon wash-out technique. A description of the method. Scand J Clin Lab Invest 1966; 18: 299–315.
Wierema TK, Houben AJ, Kroon AA, et al: Nitric oxide dependence of renal blood flow in patients with renal artery stenosis. J Am Soc Nephrol 2001; 12: 1836–1843.
van Onna M, Houben AJ, Kroon AA, et al: Asymmetry of renal blood flow in patients with moderate to severe hypertension. Hypertension 2003; 41: 108–113.
Koyama N, Ohara K, Yokota H, et al: A one step sandwich enzyme immunoassay for gamma-carboxylated osteocalcin using monoclonal antibodies. J Immunol Methods 1991; 139: 177–23.
Cockcroft DW, Gault MH : Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41.
De Leeuw PW, Birkenhäger WH : Use of the xenon-133 washout technique in diagnosing renovascular disease in hypertension. Nephron 1986; 44: 5–7.
Fraser JD, Price PA : Lung, heart, and kidney express high levels of mRNA for the vitamin K-dependent matrix Gla protein. Implications for the possible functions of matrix Gla protein and for the tissue distribution of the gamma-carboxylase. J Biol Chem 1988; 263: 11033–11036.
Cancela ML, Price PA : Retinoic acid induces matrix Gla protein gene expression in human cells. Endocrinology 1992; 130: 102–108.
Cancela ML, Hu B, Price PA : Effect of cell density and growth factors on matrix GLA protein expression by normal rat kidney cells. J Cell Physiol 1997; 171: 125–134.
Price PA, Williamson MK, Lothringer JW : Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 1981; 256: 12760–12766.
Ivaska KK, Kakonen SM, Gerdhem P, Obrant KJ, Pettersson K, Vaananen HK : Urinary osteocalcin as a marker of bone metabolism. Clin Chem 2005; 51: 618–628.
Ivaska KK, Pettersson K, Nenonen A, et al: Urinary osteocalcin is a useful marker for monitoring the effect of alendronate therapy. Clin Chem 2005; 51: 2362–2365.
Demer LL, Tintut Y : Mineral exploration: search for the mechanism of vascular calcification and beyond: the 2003 Jeffrey M. Hoeg Award lecture. Arterioscler Thromb Vasc Biol 2003; 23: 1739–1743.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rennenberg, R., Schurgers, L., Vermeer, C. et al. Renal Handling of Matrix Gla-Protein in Humans with Moderate to Severe Hypertension. Hypertens Res 31, 1745–1751 (2008). https://doi.org/10.1291/hypres.31.1745
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.1745